Hyaluronidase-enhanced delivery in gene therapy and regenerative medicine for improved vector, cell, and cargo access
Patrick E. Sewell, Christopher Jensen · 2026
Read Hyaluronidase-enhanced delivery in gene therapy and regenerative medicine for improved vector, cell, and cargo access by Patrick E. Sewell, Christopher Jensen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13582306.txt.
Description
Patrick Sewell and Christopher Jensen published a 2026 review on using an enzyme to help gene therapy and regenerative cargo reach the brain. The brain's extracellular matrix is rich in hyaluronic acid, a gel that blocks viruses, stem cells, and vesicles alike. Delivery routes through the nose and along nerves all run into this barrier.
Hyaluronidase enzymes briefly dissolve that gel, lowering viscosity and opening tissue, then the matrix rebuilds. A human version is already approved as a helper for injections under the skin, proving the approach is safe and workable. Animal studies show pretreatment boosts delivery of gene therapy viruses into the central nervous system. The review weighs the evidence for vectors, cells, and small cargo.
Catalog record
| CREATOR | Patrick E. Sewell, Christopher Jensen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 60 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |